Drug
Genexol-PM clinical trials
- studies test it
- 14
- open now
- 0
- in phase 3
- 1
- first study started
- 2007
How studies write it
Studies that test it under each name
Name
Development codes
Combined with it in one product
Studies by the year they started
14 studies that test it; most in 2008 (4)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2011 | 2 |
| 2014 | 1 |
| 2016 | 3 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 8
- Phase 3
- 1
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 5
Samyang Biopharmaceuticals Corporation (7) · Gachon University Gil Medical Center (3) · Sorrento Therapeutics, Inc. (1) · Korean Breast Cancer Study Group (1) · NantPharma, LLC (1) · National Cancer Center, Korea (1)
Often tested with
Tested in the same studies.
Gemcitabine (2) · Paclitaxel-Loaded Polymeric Micelle (1) · Doxorubicin (1) · Fluorouracil (1)
Studies
Open first, then newest update. How each study uses genexol-PM is read from its arms, and is right about nine times in ten.
Testing it · 14
- QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic CancerWithdrawnPhase 1/2NantPharma, LLCNCT03127124Written as NANT-008
- A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of SorafenibTerminatedPhase 2Gachon University Gil Medical CenterNCT03008512Written as Genexol-PM
- Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the PancreasStatus unknownPhase 2Samyang Biopharmaceuticals CorporationNCT02739633Written as Genexol-PM
- A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian CancerCompletedPhase 2Samyang Biopharmaceuticals CorporationNCT01276548Written as Genexol®-PM 260mg/m2 plus Carboplatin 5 AUC
- A Trial of Paclitaxel (Genexol®) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) and Cisplatin in Advanced Non Small Cell Lung CancerCompletedPhase 2Samyang Biopharmaceuticals CorporationNCT01023347Written as Paclitaxel loaded polymeric micelle (Genexol-PM®)
- Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic CancerCompletedPhase 1Samyang Biopharmaceuticals CorporationNCT00882973Written as Genexol-PM
- Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast CancerCompletedPhase 3Samyang Biopharmaceuticals CorporationNCT00876486Written as Genexol-PM®
- Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic CancerStatus unknownPhase 1Samyang Biopharmaceuticals CorporationNCT02739529Written as Genexol-PM
- Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast CancerCompletedNot applicableSorrento Therapeutics, Inc.NCT02064829Written as IG-001
- A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast CancerStatus unknownPhase 2Gachon University Gil Medical CenterNCT01784120Written as Doxorubicin/Genexol-PM
- A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung CancerCompletedPhase 2Gachon University Gil Medical CenterNCT01770795Written as Genexol-PM/Gemcitabine
- Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian CancerCompletedPhase 1Samyang Biopharmaceuticals CorporationNCT00877253Written as Genexol-PM 220mg/㎡, Carboplatin 5AUC
- Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer PatientsWithdrawnPhase 2National Cancer Center, KoreaNCT01169870Written as Genexol-PM
- A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast CancerStatus unknownPhase 4Korean Breast Cancer Study GroupNCT00912639Written as Paclitaxel loaded Polymeric micelle
Codes
What other systems call genexol-PM · ClinicalTrials.gg INT001371
- MeSH (NLM) C000708971genexol-PMOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000708971 | genexol-PM | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.